ALTO-203 75 μg

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
PD, PK, and Safety of ALTO-203 in Patients With MDDNCT06391593Alto NeurosciencePhase 2Completed2025-04-14Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.